Webcasts and supporting materials for recent investor presentations are available online.
Learn More
Cardiogenesis is testing novel cell therapy techniques in major clinical centers around Europe.
Learn More
Over 45,000 patients with severe coronary artery disease have been treated with Transmyocardial Revascularization.
Learn More
Cardiogenesis has many resources available for you. Go to the resource library to access clinical data, brochures, and more.
Learn MoreCardiogenesis is a progressive medical device company innovating tools for the treatment of ischemic cardiac disease.
The company, located in Irvine, California,
is the clinical and market leader in TMR (Transmyocardial Revascularization) and leading the way in advanced combination angiogenic therapies for the treatment of severe angina.